Summary
This prediction ended on 14.12.24 with a price of €180.35. The prediction had a final performance of 12.05%. BiotechBee has 80% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| UCB S.A. | -0.820% | -0.820% | 10.981% |
| iShares Core DAX® | -1,59 % | 5,03 % | 6,33 % |
| iShares Nasdaq 100 | -4,15 % | -0,13 % | 25,73 % |
| iShares Nikkei 225® | -6,30 % | 0,53 % | 41,38 % |
| iShares S&P 500 | -3,23 % | 0,47 % | 20,45 % |
According to BiotechBee what are the pros and cons of UCB S.A. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread UCB S.A. diskutieren
Buy mit Kursziel 210,0